This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Dalteparin for Primary Venous Thromboembolism (VTE...
Clinical trial

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Read time: 1 mins
Last updated:25th Aug 2009
The goal of this clinical research study is to learn if dalteparin can lower the risk of venous thromboembolism (VTE) occurring in the legs and lungs.
Category Value
Study start date 2009-08-25

View full details